Catalyst Pharmaceuticals (CPRX) Smashes Earnings With $148.4M Revenue
Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) is a commercial-stage biopharmaceutical company built around a highly focused mission: to develop and…
Browsing Tag